Gelteq Limited (GELS)
$0.45-6.25%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- -0.39
- P/E (TTM)
- -1.79
- Short % float
- 14.31%
- Days to cover
- 1.0
- SI change
- +138.2%
- 1W
- -19.64%
- 1M
- -27.42%
- vs SPY 1W
- -19.50%
- vs SPY 1M
- -29.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 4
- GROWTH
- 11
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-15.0%
REV YoY-
ROE-24.9%
EPS YoY-
ROA-18.6%
GROSS100
OP-1986
NET-2095
[VALUATION]
P/E TTM-1.79
P/E FWD-
SECTOR PE20.48
INDUSTRY PE19.11
P/B0.47
P/FCF-
EV/EBITDA-3.78
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E36.01
ALTMAN Z-
CURR RATIO0.09
ND/EBITDA-
BETA-0.39
Company news
FAQ
- What is LOPJLB’s current signal on GELS?
- LOPJLB’s latest quantitative signal on Gelteq Limited Ordinary Shares (GELS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is GELS in?
- Gelteq Limited Ordinary Shares (GELS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Gelteq Limited Ordinary Shares (GELS) do?
- Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-r…